Contents

Current Neuropharmacology, Volume 12 - Number 5

Agomelatine in the Treatment of Major Depressive Disorder: An Assessment of Benefits and Risks

, 12(5): 387 - 398

Maximilian Gahr


DOI: 10.2174/1570159X12999140619122914





Combination of Therapeutic Hypothermia and Other Neuroprotective Strategies after An Ischemic Cerebral Insult

, 12(5): 399 - 412

Joline Goossens and Said Hachimi-Idrissi


DOI: 10.2174/1570159X12666140424233036





Relevance of Excitable Media Theory and Retinal Spreading Depression Experiments in Preclinical Pharmacological Research

, 12(5): 413 - 433

V.M. Fernandes de Lima and W. Hanke


DOI: 10.2174/1570159X12666140630190800





The Gastrin-Releasing Peptide Receptor (GRPR) in the Spinal Cord as a Novel Pharmacological Target

, 12(5): 434 - 443

Keiko Takanami and Hirotaka Sakamoto


DOI: 10.2174/1570159X12666140923201432





The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review

, 12(5): 444 - 461

Gianluca Serafini, Robert H. Howland, Fabiana Rovedi, Paolo Girardi and Mario Amore


DOI: 10.2174/1570159X12666140619204251





The Endocannabinoid/Endovanilloid System and Depression

, 12(5): 462 - 474

Irena Smaga, Beata Bystrowska, Dawid Gawlinski, Edmund Przegalinski and Malgorzata Filip


DOI: 10.2174/1570159X12666140923205412





Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science